Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$10.25 USD
+0.04 (0.39%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $10.24 -0.01 (-0.10%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth F Momentum F VGM
Earnings News For TBPH
-
Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?
-
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
-
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
-
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
-
Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
-
Theravance Bio: Q4 Earnings Snapshot
-
Theravance Biopharma (TBPH) Tops Q4 Earnings and Revenue Estimates
-
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue?
-
Theravance's (TBPH) Q3 Loss Narrows, Revenues Beat Marginally
-
Theravance Bio: Q3 Earnings Snapshot
-
Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
-
Theravance Bio (TBPH) Down 2.3% Since Last Earnings Report: Can It Rebound?
-
Theravance's (TBPH) Q2 Earnings Beat Estimates, Revenues Miss
-
Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates
-
Theravance Bio: Q2 Earnings Snapshot
-
Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Why Is Theravance Bio (TBPH) Down 3.8% Since Last Earnings Report?
-
Theravance's (TBPH) Q1 Earnings and Revenues Miss Estimates
-
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
-
Theravance Bio: Q1 Earnings Snapshot
-
Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
-
Earnings Preview: Theravance Biopharma (TBPH) Q1 Earnings Expected to Decline
-
Theravance Bio (TBPH) Down 2% Since Last Earnings Report: Can It Rebound?